| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |